A prospective pilot study to investigate the effect of protein supplement on skeletal muscle mass and rehabilitative outcome in brain tumor patient

A pilot study of the effect of protein supplement on skeletal muscle mass and rehabilitative outcome in brain tumor patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009113

Enrollment

Registered

2024-01-12

Start date

2020-12-23

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The experimental group (receiving rehabilitation treatment and protein supplements) receives rehabilitation medical treatment for more than 2 hours per day, at least 5 days a week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have voluntarily given written consent in the participant consent form prior to participating in this clinical trial. 2. Patients histologically diagnosed with a brain tumor (including both benign and malignant brain tumors such as meningioma and glioma). 3. Patients who have received surgery, chemotherapy, or radiation therapy for brain tumors in neurosurgery and have limitations in daily living activities and walking due to hemiplegia or quadriplegia. 4. Patients scheduled for inpatient rehabilitation treatment for more than 4 weeks at Severance Hospital Rehabilitation Hospital.

Exclusion criteria

Exclusion criteria: 1. Individuals under 19 years of age or over 80 years of age. 2. Within the past 3 months prior to trial recruitment, having any of the following conditions: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, NYHA class III or IV congestive heart failure, stroke, or transient ischemic attack. 3. Individuals with an active infection or sepsis and undergoing antibiotic treatment. 4. Occurrence of deep vein thrombosis within 4 weeks prior to the start of trial recruitment. 5. Pregnant or nursing women. Positive pregnancy test results in women of childbearing potential. 6. Patients with liver dysfunction, acute and chronic hepatitis, or other liver function abnormalities, renal dysfunction, electrolyte imbalances requiring medication or fluid correction, or diagnosed with diabetes.

Design outcomes

Primary

Measure	Time frame
muscle mass and rehabilitation improvement	—

Secondary

Measure	Time frame
compliance	—

Countries

Korea, Republic of

Contacts

Public ContactSang Hee IM

Yonsei University

dongin32@naver.com+82-2-2228-3721

Outcome results